Top compounds associated with response to OR2M3


Feature Type Standardized
Nominal ANOVA
mRNA BMS-536924 CTRPv2 pan-cancer AAC -0.066 0.06
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.059 0.06
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.065 0.06
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.06
mRNA bid1870 gCSI pan-cancer AAC -0.099 0.06
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.064 0.06
mRNA AZD0530 CTRPv2 pan-cancer AAC -0.066 0.06
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.065 0.07
mRNA ML050 CTRPv2 pan-cancer AAC -0.067 0.07
mRNA CAY10618 CTRPv2 pan-cancer AAC 0.062 0.07
Download CSV